NLA Resources
Knowledge Center
Membership Resources
Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.
After making your filter selections, please scroll down to see results.
Cholesterol Guidelines and NLA Involvement
The National Lipid Association remains focused on enhancing the practice of lipid management in clinical medicine, with guideline education and participation as a critical part…
The Care Team Focus
The Southeast Lipid Association originated as an extension of an annual southern academic forum (Southeastern Lipid Conference) based on the science of cholesterol metabolism. A…
Origins of the NLA
In 1987, to combat the number one killer of American people, cardiovascular disease, the National Cholesterol Education Program (NCEP) released Adult Treatment Panel Guidelines to…
The Lipid Hypothesis
The lipid hypothesis states that elevated plasma cholesterol, more specifically, LDL cholesterol, has a causal role in the development of coronary heart disease and other…
NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient
Statin intolerance is defined as one or more adverse effects associated with statin therapy which resolves or improves with dose reduction or discontinuation and can…
CAC Scoring
Inclisiran: Where Will It Fit?
Inclisiran (Leqvio; Novartis) is now the first small interfering RNA (siRNA) therapy to be approved by the FDA to reduce low-density lipoprotein cholesterol (LDL-C). Inclisiran…
Enzymes in the Gut Microbiome As Contributors to Circulating Lipids
It is well established that dietary input combined with genetic predisposition can substantially alter blood lipid profiles and susceptibility of humans to diseases such as…